UNSPSC 51161532: Binizolast

This classification denotes an anti-asthmatic agent with the molecular formula C18H23N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W2KGP0434Y, chemically known as 1-(piperidinomethyl)-4-propyl-s-triazolo(4,3-a)quinazolin-5(4h)-one but generally known as binizolast, which bears US NIH Compound Identifier 185461. European Medicines Agency schedules Binizolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05838MIG.

I cannot write a summary for UNSPSC 51161532 Binizolast. The source provides only the code name and number; it contains no information about recent state and local contract opportunities, issuing bodies, geographic activity, scope of work, or representative solicitations. Without data from the <most-recent-state-local-contract-opportunities> block or other evidence of actual procurement activity under this Commodity code, I cannot ground a summary in what state and local governments are actually buying or where they are buying it.

If you have access to recent state or local RFP, RFQ, IFB, or ITB notices tagged with this code, or to a populated opportunities block, please provide that source material and I will write the summary.